poisar

Stock

Beta Bionics, Inc. BBNX

$18.08+4.33%

Overview

BBNX market data

Price History

BBNX price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.81
Diluted earnings per share over the trailing twelve months.
Beta
1.26
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-61.3%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$8.80 – $32.71
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $737.8M · P/B 4.66 · P/S 6.20.

Company News

10 captured
Beta Bionics Affirms FY2026 Sales Guidance of $131.000M-$136.000M vs $133.305M EstBenzinga · Jul 29, 2026, 8:02 PM
Beta Bionics Q2 EPS $(0.53) Beats $(0.56) Estimate, Sales $32.013M Beat $31.443M EstimateBenzinga · Jul 29, 2026, 8:02 PM
Goldman Sachs Maintains Buy on Beta Bionics, Raises Price Target to $19Benzinga · Jul 15, 2026, 4:46 PM
Truist Securities Maintains Buy on Beta Bionics, Raises Price Target to $22Benzinga · Jul 13, 2026, 4:09 PM
Robbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for InformationGlobenewswire Inc · Jun 5, 2026, 11:15 PM
Beta Bionics Announces Near Real-Time Real-World Data On iLet Bionic Pancreas Is Now Publicly Available At betabionics.com/hcp/real-world-dataBenzinga · Jun 2, 2026, 1:09 PM
Goldman Sachs Maintains Buy on Beta Bionics, Lowers Price Target to $17Benzinga · May 27, 2026, 5:35 PM
Beta Bionics Intends To Fully Commercialize Mint By Q2 2027Benzinga · May 21, 2026, 8:10 PM
8-K filing — Beta Bionics, Inc. (BBNX)SEC EDGAR · May 21, 2026, 8:06 PM
B of A Securities Maintains Neutral on Beta Bionics, Lowers Price Target to $11Benzinga · May 18, 2026, 5:35 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock